Filing Details

Accession Number:
0001213900-22-076956
Form Type:
13G Filing
Publication Date:
2022-12-01 19:00:00
Filed By:
Cadin Ltd.
Company:
Vicarious Surgical Inc. (NYSE:RBOT)
Filing Date:
2022-12-02
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Cadin Limited 0 5,081,795 0 5,081,795 4.9%
Celadon Partners 0 5,081,795 0 5,081,795 4.9%
Filing
 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

 

Vicarious Surgical Inc.

 

(Name of Issuer)

 

Class A common stock, par value $0.0001 per share

 

(Title of Class of Securities)

 

92561V109

 

(CUSIP Number)

 

November 3, 2022

 

Date of Event Which Requires Filing of this Statement

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

 

CUSIP No. 92561V109 Page 2 of 6 Pages

 

1

Name of Reporting Person:

 

Cadin Limited

2

Check the Appropriate Box if a Member of a Group

(a)

(b)

3

SEC USE ONLY

 

4

Citizenship or Place of Organization

 

Cayman Islands

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH
5

SOLE VOTING POWER

 

0

6

SHARED VOTING POWER

 

5,081,795 (1)

7

SOLE DISPOSITIVE POWER

 

0

8

SHARED DISPOSITIVE POWER

 

5,081,795 (1)

9

AGGREGATE AMOUNT BENEFICIALLY OWNED

 

5,081,795 (1)

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

4.9% (2)

12

TYPE OF REPORTING PERSON

 

OO

 

(1)Consists of (i) 4,090,236 shares of Class A common stock of the Issuer held by Cadin Limited and (ii) 991,559 shares of Class A common stock of the Issuer underlying warrants held by Cadin Limited which are exercisable within 60 days of the date hereof. Pursuant to the Warrant Agreement, on November 3, 2022, Cadin Limited provided notice to the Issuer limiting Cadin Limited’s ability to exercise its warrants such that its ownership of the outstanding Class A common stock of the Issuer shall not exceed 4.9% (the “Blocker”). Cadin Limited disclaims any beneficial ownership of the securities reported herein except to the extent of any pecuniary interest it may have therein, directly or indirectly.

 

(2)Based on a total of 103,710,110 shares of Class A common stock outstanding consisting of (i) 102,718,551 shares of Class A common stock outstanding as of November 1, 2022, as reported in the Issuer’s Form 10-Q (File No. 001-39384) filed with the Securities and Exchange Commission on November 7, 2022 and (ii) 991,559 shares of Class A common stock of the Issuer underlying warrants held by Cadin Limited which are exercisable within 60 days of the date hereof, excluding the warrants held by Cadin Limited subject to the Blocker.

 

 

 

 

CUSIP No. 92561V109 Page 3 of 6 Pages

 

1

Name of Reporting Person:

 

Celadon Partners, LLC

2

Check the Appropriate Box if a Member of a Group

(a)

(b)

3

SEC USE ONLY

 

4

Citizenship or Place of Organization

 

Cayman Islands

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH
5

SOLE VOTING POWER

 

0

6

SHARED VOTING POWER

 

5,081,795 (1)

7

SOLE DISPOSITIVE POWER

 

0

8

SHARED DISPOSITIVE POWER

 

5,081,795 (1)

9

AGGREGATE AMOUNT BENEFICIALLY OWNED

 

5,081,795 (1)

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

4.9% (2)

12

TYPE OF REPORTING PERSON

 

OO

 

(1)Consists of (i) 4,090,236 shares of Class A common stock of the Issuer held by Cadin Limited and (ii) 991,559 shares of Class A common stock of the Issuer underlying warrants held by Cadin Limited which are exercisable within 60 days of the date hereof. Pursuant to the Warrant Agreement, on November 3, 2022, Cadin Limited provided notice to the Issuer instituting the Blocker. Cadin Limited disclaims any beneficial ownership of the securities reported herein except to the extent of any pecuniary interest it may have therein, directly or indirectly.

 

(2)Based on a total of 103,710,110 shares of Class A common stock outstanding consisting of (i) 102,718,551 shares of Class A common stock outstanding as of November 1, 2022, as reported in the Issuer’s Form 10-Q (File No. 001-39384) filed with the Securities and Exchange Commission on November 7, 2022 and (ii) 991,559 shares of Class A common stock of the Issuer underlying warrants held by Cadin Limited which are exercisable within 60 days of the date hereof, excluding the warrants held by Cadin Limited subject to the Blocker.

 

 

 

 

CUSIP No. 92561V109 Page 4 of 6 Pages

 

SCHEDULE 13G/A

 

Item 1(a)Name of Issuer:

 

Vicarious Surgical Inc. (the “Issuer”)

 

Item 1(b)Address of Issuer’s Principal Executive Offices:

 

78 Fourth Avenue

Waltham, Massachusetts 02451

 

Item 2(a)Name of Persons Filing:

 

This statement is filed on behalf of each of the following persons (each, a “Reporting Person”):

 

1.Cadin Limited; and

 

2.Celadon Partners, LLC.

 

The securities reported herein are held directly by Cadin Limited. Celadon Partners, LLC is the sole director of Cadin Limited and shares voting and dispositive power over the securities held directly by Cadin Limited. As a result, Celadon Partners, LLC may be deemed to have or share beneficial ownership of the securities held directly by the Cadin Limited. Each Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest therein.

 

Item 2(b)Address of Principal Business Office, or if None, Residence:

 

The principal business address of each Reporting Person is as follows:

 

Suite 2810-12, One Pacific Place

88 Queensway, Admiralty, Hong Kong

 

Item 2(c)Citizenship:

 

See responses to row 4 of the cover page for each Reporting Person.

 

Item 2(d)Title of Class of Securities: Class A common stock, par value $0.0001 per share

 

Item 2(e)CUSIP Number: 92561V109

 

Item 3If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is:

 

Not applicable.

 

Item 4Ownership:

 

The information required by Items 4(a)-(c) is set forth in Rows 5-11 of the cover pages hereto for each Reporting Person and is incorporated herein by reference for each Reporting Person.

 

Item 5Ownership of Five Percent or Less of the Class:

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☒.

 

 

 

 

CUSIP No. 92561V109 Page 5 of 6 Pages

 

Item 6Ownership of More Than Five Percent on Behalf of Another Person:

 

Not Applicable.

 

Item 7Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:

 

Not Applicable.

 

Item 8Identification and Classification of Members of the Group:

 

Not Applicable.

 

Item 9Notice of Dissolution of Group:

 

Not Applicable.

 

Item 10Certification:

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

 

 

 

 

CUSIP No. 92561V109 Page 6 of 6 Pages

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Date: December 2, 2022

 

  CADIN LIMITED
     
  By: Celadon Partners, LLC, its director
     
  By: /s/ John Cullinane
  Name:   John Cullinane
  Title: Manager
     
  CELADON PARTNERS, LLC
     
  By: /s/ John Cullinane
  Name: John Cullinane
  Title: Manager